V.b
V - Myocarditis
Eosinophilic myocarditis
Last update 17/06/2026
Back
The Drug-Induced Respiratory Disease Website
Causative drugs
10
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
XVI.e
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV.f
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.f Diffuse alveolar damage (DAD) imaging pattern
XXIV.h
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.h Pulmonary fibrosis (may improve but partly following drug discontinuation)
XXIV.j
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.j Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)
XXVIII.a
XXVIII. Large airway involvement
XXVIII.a Angioedema (may cause UAO, asphyxia and death)
XXXVIII.k
XXXVIII. Miscellaneous - Varia
XXXVIII.k Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.g
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.g QTc prolongation
I.l
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.l Cardiac- cardiorespiratory/pulmonary arrest
I.n
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.n Respiratory arrest - Apnea
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
VI.a
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
VI.a
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
VII.a
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
XII.n
XII. Pericardial involvement
XII.n Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)
XIII.a
XIII. Thrombosis - Embolism
XIII.a Pulmonary embolism - Venous thrombosis/thrombo-embolism
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXVIII.a
XXVIII. Large airway involvement
XXVIII.a Angioedema (may cause UAO, asphyxia and death)
XXIX.a
XXIX. Small airway involvement
XXIX.a Bronchospasm - Wheezing - Asthma
XXXIII.b
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.b Path: Lymphocytic myocarditis
XXXIII.c
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.c Path: Eosinophilic myocarditis
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.l
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.l Cardiac- cardiorespiratory/pulmonary arrest
II.a
II. Myocardial dysfunction - Heart failure
II.a Left ventricular dysfunction/failure
III.a
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
V.f
V. Myocarditis
V.f Myopericarditis
V.h
V. Myocarditis
V.h Relapse of previously diagnosed myocarditis
VI.c
VI. Cardiomyopathy
VI.c Takotsubo (stress) cardiomyopathy
X.a
X. Pulmonary edema
X.a Pulmonary edema, cardiogenic
XI.a
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XI.j
XI. Pulmonary vasculopathies
XI.j Pulmonary infarction
XII.a
XII. Pericardial involvement
XII.a Pericarditis
XII.b
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XII.e
XII. Pericardial involvement
XII.e Constrictive pericarditis - Pericardial thickening
XIII.a
XIII. Thrombosis - Embolism
XIII.a Pulmonary embolism - Venous thrombosis/thrombo-embolism
XV.a
XV. Chest pain
XV.a Chest pain (acute or subacute), lone or prominent
XVI.e
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XVI.h
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.h Coagulopathy
XX.c
XX. Vasculitis
XX.c Vascultis (pulmonary, extrathoracic or systemic) - ANCA status unknown or negative
XX.d
XX. Vasculitis
XX.d Vasculitis, pulmonary (w/wo AH), extrathoracic, or systemic: ANCA-positive
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV.i
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.i Progression, acceleration or exacerbation of preexisting ILD/fibrosis
XXIV.v
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.v Radiation recall pneumonitis
XXIX.a
XXIX. Small airway involvement
XXIX.a Bronchospasm - Wheezing - Asthma
XXIX.h
XXIX. Small airway involvement
XXIX.h Exacerbation or deterioration of preexisting asthma
XXX.l
XXX. Imaging features
XXX.l Imaging: Ground-glass opacities / GGO shadowing
XXX.p
XXX. Imaging features
XXX.p Imaging: Asymmetrical, predominantly unilateral involvement
XXX.s
XXX. Imaging features
XXX.s Imaging: A mosaic pattern of attenuation
XXXVI.b
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.b Lupus - Lupus syndrome
XXXVI.f
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXXVI.i
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.i Guillain-Barré (or GB-like) syndrome (w/wo ARF)
XXXVI.j
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.j Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
XXXVI.n
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.n A flare of preexisting immune-mediated systemic/rheumatic disease
XXXVI.x
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.x Anti Jo1 syndrome
XXXVI.z
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.z Protracted, prolonged anaphylaxis
XXXVI.ae
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.ae Polyarteritis nodosa-like condition
XXXVIII.c
XXXVIII. Miscellaneous - Varia
XXXVIII.c Antiphospholipid antibodies w/wo the APL syndrome
XXXVIII.q
XXXVIII. Miscellaneous - Varia
XXXVIII.q Myopathy-Myositis-Polymyositis
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.e
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.e Bradycardia
I.f
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.f Tachycardia
I.j
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.j Asystole
I.l
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.l Cardiac- cardiorespiratory/pulmonary arrest
II.d
II. Myocardial dysfunction - Heart failure
II.d Cardiovascular collapse - Cardiogenic shock - Hypotension
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
VI.a
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
VII.a
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
VII.b
VII. Cardiotoxicity
VII.b Veterinary: Cardiotoxicity
XIV.a
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XVI.e
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV.j
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.j Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)
XXIV.s
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.s ILD with a granulomatous component
XXXIII.c
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.c Path: Eosinophilic myocarditis
XXXVI.b
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.b Lupus - Lupus syndrome
XXXVI.m
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.m DRES syndrome - DRESS-like reaction - Drug hypersensitivity syndrome
II.a
II. Myocardial dysfunction - Heart failure
II.a Left ventricular dysfunction/failure
II.d
II. Myocardial dysfunction - Heart failure
II.d Cardiovascular collapse - Cardiogenic shock - Hypotension
III.a
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
V.f
V. Myocarditis
V.f Myopericarditis
X.a
X. Pulmonary edema
X.a Pulmonary edema, cardiogenic
XII.a
XII. Pericardial involvement
XII.a Pericarditis
XII.b
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XII.n
XII. Pericardial involvement
XII.n Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)
XIV.a
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XIV.d
XIV. Pleural involvement
XIV.d Eosinophilic pleural effusion
XV.a
XV. Chest pain
XV.a Chest pain (acute or subacute), lone or prominent
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV.d
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.d Acute eosinophilic pneumonia (AEP)
XXIV.j
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.j Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)
XXIV.p
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.p An area or areas of consolidation
XXIV.s
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.s ILD with a granulomatous component
XXVIII.m
XXVIII. Large airway involvement
XXVIII.m Bronchiectasis
XXXVI.b
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.b Lupus - Lupus syndrome
XXXVI.m
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.m DRES syndrome - DRESS-like reaction - Drug hypersensitivity syndrome
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
XX.c
XX. Vasculitis
XX.c Vascultis (pulmonary, extrathoracic or systemic) - ANCA status unknown or negative
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXXVI.f
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)